Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Nikos Maniadakis"'
Autor:
Zsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, Kateřina Podrazilová, Tomáš Tesař, Nikos Maniadakis, Frank-Ulrich Fricke, András Inotai
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Medicines that are based on known molecules and are further developed to address healthcare needs and deliver relevant improvement for patients, healthcare professionals and/or payers are called value-added medicines (VAMs). The e
Externí odkaz:
https://doaj.org/article/8e1bcfec41624ce1940e2ea5de2061f0
Autor:
Zoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, Nikos Maniadakis, Tomáš Tesař, Kateřina Podrazilová, Jaime Espin, András Inotai
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background A core evaluation framework that captures the health care and societal benefits of value added medicines (VAMs, also often called repurposed medicines) was proposed in Report 1, aiming to reduce the heterogeneity in value assessme
Externí odkaz:
https://doaj.org/article/21d9cfc512d44c0598b4a76e7a3c05e0
Autor:
Georgia Kourlaba, Garyfallia Stefanou, Sotiris Tsalamandris, Evangelos Oikonomou, Giannis Papageorgiou, Nikos Nikas, Dimitris Tousoulis, Nikos Maniadakis
Publikováno v:
Hellenic Journal of Cardiology, Vol 62, Iss 3, Pp 234-240 (2021)
Background: To estimate the incidence of hemorrhagic events in patients with atrial fibrillation (AF) treated with acenocoumarol, and the management cost of those requiring hospitalization in Greece. Methods: A nationwide telephone survey was conduct
Externí odkaz:
https://doaj.org/article/529a707814a942c4859141c5ce021441
Autor:
Andras Inotai, Diana Brixner, Nikos Maniadakis, Iwan Dwiprahasto, Erna Kristin, Agus Prabowo, Alfi Yasmina, Sigit Priohutomo, Bertalan Németh, Kalman Wijaya, Zoltan Kalo
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Off-patent pharmaceuticals (OPPs) hold vital importance in meeting public health objectives, especially in developing countries where resources are limited. OPPs are comprised of off-patent originals, branded generics and unbrande
Externí odkaz:
https://doaj.org/article/3930c836e0ee488d93f313a46fad72d9
Autor:
Elena Fountzilas, Sofia Levva, Giannis Mountzios, Genovefa Polychronidou, Nikos Maniadakis, Vassiliki Kotoula, George Fountzilas
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-12 (2018)
Purpose: Because of the profound financial crisis that commenced in Greece in 2010, severe cuts in health care spending and other restriction measures led to significant delays in the reimbursement of novel antineoplastic agents. In 2011, the Helleni
Externí odkaz:
https://doaj.org/article/7661070ee8764ae1968e7b21fd698d1f
Autor:
Roger von Moos, Jean-Jacques Body, Oliver Guenther, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot, Harm Sleeboom
Publikováno v:
Journal of Bone Oncology, Vol 10, Iss C, Pp 49-56 (2018)
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer and can lead to debilitating complications (skeletal-related events [SREs]), including requirement for radiation to bone. Despite the high frequency o
Externí odkaz:
https://doaj.org/article/eb7c23d709e04c5093ed19529f04fb48
Autor:
Nikos Maniadakis, Vasilios Fragoulakis, Charalambos Mylonas, Rakesh Sharma, Andrew J Stewart Coats
Publikováno v:
International Cardiovascular Forum Journal, Vol 4, Pp 43-52 (2015)
Aims: Heart failure represents a major burden for health systems and societies. Cardiac contractility modulation (CCM) therapy was developed in recent years for patients with normal QRS in whom optimal pharmacological (OMT) treatment has failed to co
Externí odkaz:
https://doaj.org/article/76d4ed8f556645479288f34e7777cfb2
Autor:
Mamas Theodorou, Panagiotis Stafylas, Georgia Kourlaba, Daphne Kaitelidou, Nikos Maniadakis, Vasilios Papademetriou
Publikováno v:
International Journal of Hypertension, Vol 2012 (2012)
Background. The aim of the current study was to investigate physicians’ perceptions and adherence to the European guidelines for the management of hypertension. Methods. This is a national, multicentre, prospective, observational study, conducted b
Externí odkaz:
https://doaj.org/article/b9e8e90869f04d7790fb9efb0f438e64
Autor:
Isidoros kougioumtzoglou, Panagiotis rigopoulos, Apostolos stratopoulos, Kalliopi mortaki, Areti lagiou, Nikos maniadakis, Dimitrios kouvelas
Publikováno v:
Population Medicine. 5
Autor:
Tomáš Tesař, Kateřina Podrazilová, Zoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, Jaime Espín, Nikos Maniadakis, András Inotai
Publikováno v:
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-9 (2021)
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-9 (2021)
Background Medicines that are based on known molecules and are further developed to address healthcare needs and deliver relevant improvement for patients, healthcare professionals and/or payers are called value-added medicines (VAMs). The evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0166d1a7070bfe9756122bc2d789dd4d
https://hdl.handle.net/10668/18485
https://hdl.handle.net/10668/18485